Answer
It is unknown whether crovalimab passes into human breast milk; human IgG1 is excreted in milk, risk to the infant cannot be excluded, and a decision to discontinue breast-feeding or PiaSky therapy must consider the benefits of breast-feeding for the infant and therapy for the mother.
Sources for this answer
- PiaSky 340 mg solution for injection/infusionRoche Products Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked